FDA Inspection 1121677 — Labcorp Early Development Laboratories, Inc.
The FDA completed an inspection of Labcorp Early Development Laboratories, Inc. on February 14, 2020 in Madison, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 14, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Madison, WI (United States)
Additional Details
Bioanalytical BA/BE